XML 70 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders Equity
12 Months Ended
Dec. 31, 2020
Stockholders' Equity  
Stockholders' Equity

Note 21. Stockholders’ Equity

Common stock dividends

The following table presents cash dividends declared by our board of directors on our common stock from January 1, 2019 through December 31, 2020:

    

    

    

Declaration Date

Record Date

Payment Date

Dividend per Share

March 12, 2019

March 28, 2019

April 30, 2019

$

0.40

June 11, 2019

June 28, 2019

July 31, 2019

$

0.40

September 10, 2019

September 30, 2019

October 31, 2019

$

0.40

December 11, 2019

December 31, 2019

January 31, 2020

$

0.40

March 11, 2020

March 31, 2020

April 30, 2020

$

0.40

(1)

June 15, 2020

June 30, 2020

July 31, 2020

$

0.25

September 16, 2020

September 30, 2020

October 30, 2020

$

0.30

December 14, 2020

December 31, 2020

January 29, 2021

$

0.35

(1)Dividends paid in a combination of cash, not to exceed 20% in the aggregate, and common stock.

Stock incentive plan

The Company currently maintains the 2012 equity incentive plan (“the 2012 Plan”). The 2012 Plan authorizes the Compensation Committee to approve grants of equity-based awards to our officers, directors, and employees of our Manager and its affiliates. The equity incentive plan provides for grants of equity-based awards up to an aggregate of 5% of the shares of the Company’s common stock issued and outstanding from time to time on a fully diluted basis.

The Company’s current policy for issuing shares upon settlement of stock-based incentive awards is to issue new shares. The fair value of the RSUs and RSAs granted, which is determined based upon the stock price on the grant date, is recorded as compensation expense on a straight-line basis over the vesting periods for the awards, with an offsetting increase in stockholders’ equity.

The following table summarizes the Company’s RSU and RSA activity for the year ended December 31, 2020:

Restricted Stock Awards

(In Thousands, except share data)

Number of
Shares

    

Grant date fair value

Weighted-average grant date fair value (per share)

Outstanding, January 1

1,009,617

$

15,722

$

15.57

Granted

208,514

 

3,298

15.82

Vested

(60,370)

(894)

14.81

Outstanding, March 31, 2020

1,157,761

 

$

18,126

$

15.66

Vested

(16,452)

(227)

13.78

Outstanding, June 30, 2020

1,141,309

 

$

17,900

$

15.68

Granted

17,200

200

11.63

Vested

(26,602)

(320)

12.03

Forfeited

(2,258)

(37)

16.26

Outstanding, September 30, 2020

1,129,649

 

$

17,743

$

15.71

Vested

(254,521)

(3,958)

15.55

Canceled

(3,049)

(48)

15.86

Outstanding, December 31, 2020

872,079

 

$

13,737

$

15.75

During the years ended December 31, 2020 and 2019, the Company recognized $5.4 million and $1.5 million, respectively of noncash compensation expense related to its stock-based incentive plan in our consolidated statements of income, respectively.

At December 31, 2020 and 2019, approximately $13.7 million and $15.7 million, respectively of noncash compensation expense related to unvested awards had not yet been charged to net income. These costs are expected to be amortized into compensation expense ratably over the course of the remainder of the respective vesting periods.